Association of Lipoprotein(a) with cardiovascular events among individuals with autoimmune conditions
Pamela L. Alebna(University of California San Diego), Anurag Mehta(Pacific University Oregon), M. Antonia Martín(Virginia Commonwealth University), Benjamín Van Tassell(Virginia Commonwealth University), Fadi N. Salloum(Virginia Commonwealth University), Garima Sharma(Inova Fairfax Hospital), Jared Spitz(Johns Hopkins Hospital), W. Gregory Hundley(Virginia Commonwealth University), Sarah Martey(Virginia Commonwealth University), Dave L. Dixon(Joint Commission)
Cited by 6
Related Papers
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure
|Journal of Cardiac Failure|2022|406
2020 ACC/AHA guideline for the management of patients with valvular heart disease
|Journal of Thoracic and Cardiovascular Surgery|2021|262
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy
|Journal of Thoracic and Cardiovascular Surgery|2021|91
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases
|ACS Medicinal Chemistry Letters|2012|58
B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
|Journal of the American Heart Association|2020|20